BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Porteous MK, Lee JC. Primary Graft Dysfunction After Lung Transplantation. Clin Chest Med 2017;38:641-54. [PMID: 29128015 DOI: 10.1016/j.ccm.2017.07.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Murdaca G, Tonacci A, Negrini S, Greco M, Borro M, Puppo F, Gangemi S. Effects of AntagomiRs on Different Lung Diseases in Human, Cellular, and Animal Models. Int J Mol Sci 2019;20:E3938. [PMID: 31412612 DOI: 10.3390/ijms20163938] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
2 Chen C, Zheng Q, Wu D, Song Y, Xu G. Review of outcomes of delayed chest closure following lung transplantation: a meta-analysis. J Cardiothorac Surg 2022;17:122. [PMID: 35590331 DOI: 10.1186/s13019-022-01868-w] [Reference Citation Analysis]
3 Wang L, Chen B, Xiong X, Chen S, Jin L, Zhu M. Necrostatin-1 Synergizes the Pan Caspase Inhibitor to Attenuate Lung Injury Induced by Ischemia Reperfusion in Rats. Mediators Inflamm 2020;2020:7059304. [PMID: 33162831 DOI: 10.1155/2020/7059304] [Reference Citation Analysis]
4 Pacheco SE, Stark JM. Pulmonary Manifestations of Immunodeficiency and Immunosuppressive Diseases Other than Human Immunodeficiency Virus. Pediatr Clin North Am 2021;68:103-30. [PMID: 33228927 DOI: 10.1016/j.pcl.2020.09.004] [Reference Citation Analysis]
5 Talaie T, DiChiacchio L, Prasad NK, Pasrija C, Julliard W, Kaczorowski DJ, Zhao Y, Lau CL. Ischemia-reperfusion Injury in the Transplanted Lung: A Literature Review. Transplant Direct 2021;7:e652. [PMID: 33437867 DOI: 10.1097/TXD.0000000000001104] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
6 Barile M. Pulmonary Edema: A Pictorial Review of Imaging Manifestations and Current Understanding of Mechanisms of Disease. Eur J Radiol Open 2020;7:100274. [PMID: 33163585 DOI: 10.1016/j.ejro.2020.100274] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Quan L, Zheng B, Zhou H. Protective effects of molecular hydrogen on lung injury from lung transplantation. Exp Biol Med (Maywood) 2021;246:1410-8. [PMID: 33899545 DOI: 10.1177/15353702211007084] [Reference Citation Analysis]
8 Li J, Wei L, Han Z, Chen Z, Zhang Q. Long non-coding RNA X-inactive specific transcript silencing ameliorates primary graft dysfunction following lung transplantation through microRNA-21-dependent mechanism. EBioMedicine 2020;52:102600. [PMID: 31981974 DOI: 10.1016/j.ebiom.2019.102600] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
9 Daoud D, Chacon Alberty L, Wei Q, Hochman Mendez C, Virk MHM, Mase J, Jindra P, Cusick M, Choi H, Debolske N, Sampaio LC, Taylor DA, Loor G. Incidence of primary graft dysfunction is higher according to the new ISHLT 2016 guidelines and correlates with clinical and molecular risk factors. J Thorac Dis 2021;13:3426-42. [PMID: 34277039 DOI: 10.21037/jtd-20-3564] [Reference Citation Analysis]
10 Natalini JG, Diamond JM, Porteous MK, Lederer DJ, Wille KM, Weinacker AB, Orens JB, Shah PD, Lama VN, McDyer JF, Snyder LD, Hage CA, Singer JP, Ware LB, Cantu E, Oyster M, Kalman L, Christie JD, Kawut SM, Bernstein EJ. Risk of primary graft dysfunction following lung transplantation in selected adults with connective tissue disease-associated interstitial lung disease. J Heart Lung Transplant 2021;40:351-8. [PMID: 33637413 DOI: 10.1016/j.healun.2021.01.1391] [Reference Citation Analysis]
11 Wang X, Parapanov R, Debonneville A, Wang Y, Abdelnour‐berchtold E, Gonzalez M, Gronchi F, Perentes J, Ris H, Eckert P, Piquilloud L, Lugrin J, Letovanec I, Krueger T, Liaudet L. Treatment with 3‐aminobenzamide during ex vivo lung perfusion of damaged rat lungs reduces graft injury and dysfunction after transplantation. Am J Transplant 2020;20:967-76. [DOI: 10.1111/ajt.15695] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
12 Forgie KA, Fialka N, Freed DH, Nagendran J. Lung Transplantation, Pulmonary Endothelial Inflammation, and Ex-Situ Lung Perfusion: A Review. Cells 2021;10:1417. [PMID: 34200413 DOI: 10.3390/cells10061417] [Reference Citation Analysis]
13 Xu J, Li W, Xu S, Gao W, Yu Z. Effect of dermatan sulphate on a C57-mouse model of pulmonary fibrosis. J Int Med Res 2019;47:2655-65. [PMID: 31006321 DOI: 10.1177/0300060519842048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Jungraithmayr W. Novel Strategies for Endothelial Preservation in Lung Transplant Ischemia-Reperfusion Injury. Front Physiol 2020;11:581420. [PMID: 33391010 DOI: 10.3389/fphys.2020.581420] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Hitz AM, Bläsing KA, Wiegmann B, Bellmàs-Sanz R, Chichelnitskiy E, Wandrer F, Horn LM, Neudörfl C, Keil J, Beushausen K, Ius F, Sommer W, Avsar M, Kühn C, Tudorache I, Salman J, Siemeni T, Haverich A, Warnecke G, Falk CS, Kühne JF. Donor NK and T Cells in the Periphery of Lung Transplant Recipients Contain High Frequencies of Killer Cell Immunoglobulin-Like Receptor-Positive Subsets. Front Immunol 2021;12:778885. [PMID: 34966390 DOI: 10.3389/fimmu.2021.778885] [Reference Citation Analysis]
16 Zhou J, Chen B, Liao H, Wang Z, Lyu M, Man S, Pu Q, Liu L. The Comparable Efficacy of Lung Donation After Circulatory Death and Brain Death: A Systematic Review and Meta-analysis. Transplantation 2019;103:2624-33. [DOI: 10.1097/tp.0000000000002888] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
17 Patel PM, Connolly MR, Coe TM, Calhoun A, Pollok F, Markmann JF, Burdorf L, Azimzadeh A, Madsen JC, Pierson RN 3rd. Minimizing Ischemia Reperfusion Injury in Xenotransplantation. Front Immunol 2021;12:681504. [PMID: 34566955 DOI: 10.3389/fimmu.2021.681504] [Reference Citation Analysis]
18 Moreno Garijo J, Roscoe A. Ex-vivo lung perfusion. Curr Opin Anaesthesiol 2020;33:50-4. [PMID: 31688085 DOI: 10.1097/ACO.0000000000000804] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Luo Q, Zhu L, Wang Y, Wang L, Lv W, Hu J. The Conversional Efficacy of Ex Vivo Lung Perfusion and Clinical Outcomes in Patients Undergoing Transplantation of Donor Lungs by Ex Vivo Lung Perfusion: A Meta-Analysis. Ann Transplant 2019;24:647-60. [PMID: 31879416 DOI: 10.12659/AOT.919242] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Rosenheck J, Pietras C, Cantu E. Early Graft Dysfunction after Lung Transplantation. Curr Pulmonol Rep 2018;7:176-87. [PMID: 31548919 DOI: 10.1007/s13665-018-0213-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Rudasill SE, Sanaiha Y, Kwon M, Mardock AL, Khoury H, Omari B, Rabkin DG, Benharash P. Understanding lung transplant listing practices: Survival in lung transplant candidates who improve clinically to delisting. Surgery 2019;166:1142-7. [PMID: 31421870 DOI: 10.1016/j.surg.2019.07.009] [Reference Citation Analysis]
22 Natalini JG, Diamond JM. Primary Graft Dysfunction. Semin Respir Crit Care Med 2021;42:368-79. [PMID: 34030200 DOI: 10.1055/s-0041-1728794] [Reference Citation Analysis]
23 Van Slambrouck J, Van Raemdonck D, Vos R, Vanluyten C, Vanstapel A, Prisciandaro E, Willems L, Orlitová M, Kaes J, Jin X, Jansen Y, Verleden GM, Neyrinck AP, Vanaudenaerde BM, Ceulemans LJ. A Focused Review on Primary Graft Dysfunction after Clinical Lung Transplantation: A Multilevel Syndrome. Cells 2022;11:745. [PMID: 35203392 DOI: 10.3390/cells11040745] [Reference Citation Analysis]
24 Iske J, Hinze CA, Salman J, Haverich A, Tullius SG, Ius F. The potential of ex vivo lung perfusion on improving organ quality and ameliorating ischemia reperfusion injury. Am J Transplant 2021. [PMID: 34355495 DOI: 10.1111/ajt.16784] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
25 Roesel MJ, Sharma NS, Schroeter A, Matsunaga T, Xiao Y, Zhou H, Tullius SG. Primary Graft Dysfunction: The Role of Aging in Lung Ischemia-Reperfusion Injury. Front Immunol 2022;13:891564. [PMID: 35686120 DOI: 10.3389/fimmu.2022.891564] [Reference Citation Analysis]
26 Li JW, Wei L, Han Z, Chen Z. Mesenchymal stromal cells-derived exosomes alleviate ischemia/reperfusion injury in mouse lung by transporting anti-apoptotic miR-21-5p. Eur J Pharmacol. 2019;852:68-76. [PMID: 30682335 DOI: 10.1016/j.ejphar.2019.01.022] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 16.7] [Reference Citation Analysis]
27 Selim J, Hamzaoui M, Boukhalfa I, Djerada Z, Chevalier L, Piton N, Genty D, Besnier E, Clavier T, Dumesnil A, Renet S, Mulder P, Doguet F, Tamion F, Veber B, Richard V, Baste JM. Cardiopulmonary bypass increases endothelial dysfunction after pulmonary ischaemia-reperfusion in an animal model. Eur J Cardiothorac Surg 2021;59:1037-47. [PMID: 33276375 DOI: 10.1093/ejcts/ezaa412] [Reference Citation Analysis]